ADVANCED SOFT-TISSUE SARCOMA
Clinical trials for ADVANCED SOFT-TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT-TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT-TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and cabozantinib, in people with advanced sarcomas that have not responded to standard treatments. The goal is to see if this combo can stop or shrink tumors for at least 6 months. About 119 adults with specific sarcoma t…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 26, 2026 07:50 UTC
-
Promising combo targets rare sarcoma in new trial
Disease control Recruiting nowThis study tests whether combining two drugs—atezolizumab (an immunotherapy) and selinexor (a growth blocker)—can shrink tumors in people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. About 27 adults with this cancer will re…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Can a gentle chemo keep sarcoma at bay? new trial aims to find out.
Disease control Recruiting nowThis study is for people with advanced soft tissue sarcoma whose disease is under control after standard chemotherapy. It compares taking a maintenance drug called pegylated liposomal doxorubicin (PLD) versus simply monitoring the cancer. The goal is to see if PLD can delay the c…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for sarcoma: drug combo aims to slow tumor growth
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcoma that has spread. The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from multiplying. The goal is to see if this combination is safer and works better than the current s…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Radioactive drug targets Hard-to-Treat sarcoma in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [Ac225]-RTX-2358, in 30 adults with advanced soft tissue sarcoma that has returned or not responded to prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Partici…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC